This inventor holds 2 USPTO granted patents. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Tetsutaro Mimura: Innovator in Pharmaceutical Chemistry
Introduction
Tetsutaro Mimura is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on N-substituted mercaptopropanamide derivatives. With a total of 2 patents, his research focuses on compounds that have potential therapeutic applications.
Latest Patents
Mimura's latest patents involve novel N-substituted mercaptopropanamide derivatives. These compounds are characterized by a specific formula where R₁ is mercapto or a group convertible into mercapto when cleaved within the biobody. The compounds exhibit excellent enkephalinase inhibitory activity, making them useful for the treatment of mild to moderate pain. Additionally, the patents describe a pharmaceutical composition containing these compounds as an active ingredient, along with processes for their preparation.
Career Highlights
Tetsutaro Mimura is associated with Dainippon Pharmaceutical Company, Limited, where he continues to advance his research in pharmaceutical innovations. His work has contributed to the development of new therapeutic agents that can improve patient care.
Collaborations
Mimura has collaborated with notable coworkers such as Yasuhisa Nakamura and Junko Nishino. Their combined efforts have furthered the research and development of innovative pharmaceutical solutions.
Conclusion
Tetsutaro Mimura's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in pain management therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
